LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Lowering Sarepta Therapeutics (SRPT) Q1 26 Rev. Estimate To 385.7 M From 470.6 M 12/9/2025 7:31:23 AM
  • Wedbush Is Raising Sarepta Therapeutics (SRPT) FY 25 Rev. Estimate To 2018 M From 1668 M 12/9/2025 7:31:12 AM
  • Wedbush Is Cutting Sarepta Therapeutics (SRPT) Q4 25 Rev. Estimate To 401.5 M From 421.3 M 12/9/2025 7:31:01 AM
  • Wedbush Is Cutting Sarepta Therapeutics (SRPT) FY 26 Estimate To -2.06 From 1.17 12/9/2025 7:30:36 AM
  • Wedbush Is Lowering Sarepta Therapeutics (SRPT) Q4 26 Estimate To -0.07 From 0.23 12/9/2025 7:30:23 AM
  • Wedbush Is Lowering Sarepta Therapeutics (SRPT) Q3 26 Estimate To -0.17 From 0.30 12/9/2025 7:30:11 AM
  • Wedbush Is Lowering Sarepta Therapeutics (SRPT) Q2 26 Estimate To -0.29 From 0.30 12/9/2025 7:29:59 AM
  • Wedbush Is Lowering Sarepta Therapeutics (SRPT) Q1 26 Estimate To -0.40 From 0.34 12/9/2025 7:29:32 AM
  • Wedbush Is Lowering Sarepta Therapeutics (SRPT) FY 25 Estimate To -5.53 From 0.52 12/9/2025 7:29:20 AM
  • Wedbush Is Cutting Sarepta Therapeutics (SRPT) Q4 25 Estimate To 0.03 From 0.06 12/9/2025 7:29:08 AM
  • Wedbush Initiates Sarepta Therapeutics (SRPT) At Outperform With $32 Price Target 12/9/2025 7:28:07 AM
  • Sarepta Therapeutics Announces Refinancing Of About $700 Mln Of 1.25% Convertible Senior Notes Due 2027 8/21/2025 7:26:50 AM
  • Sarepta Therapeutics Announces Advancement Of SiRNA Collaboration And Sale Of Arrowhead Equity Investment 8/13/2025 4:22:34 PM